颈内动脉狭窄进展的自然史
这项单机构回顾性队列研究分析了2015至2022年超声诊断的颈内动脉狭窄≥50%的患者,发现21.3%的非闭塞性病变出现狭窄程度进展,平均进展时间28.0±20.5个月,5.6%患者出现症状,16.6%病变接受干预,作者建议对所有颈动脉疾病患者进行长期监测。
要点
- 非闭塞性颈内动脉狭窄中21.3%出现进展,平均进展时间28.0±20.5个月。
- 年龄较大、糖尿病和血管炎病史与狭窄进展相关,抗血小板药物使用呈减少进展趋势。
- 5.6%患者出现症状,16.6%病变接受干预,其中81%干预为无症状病变。
核心结论
- 相当数量的颈动脉狭窄患者经历疾病进展,医生应考虑对所有颈动脉疾病患者进行长期监测,尤其关注有进展危险因素者,特别是糖尿病和血管炎病史患者。
研究设计与样本
- 单机构回顾性队列研究,分析2015至2022年超声诊断的颈内动脉狭窄≥50%的患者,来源于本机构Intersocietal Accreditation Commission认证的非介入血管实验室数据库。
- 共纳入467例患者的577条动脉,指数研究时平均年龄73.5±8.9岁,45.0%(n=210)为女性,超声随访平均42.2±22.7个月。
主要发现
- 577条动脉中,指数影像时65.5%(n=378)为中度(50%-69%)狭窄,23.7%(n=137)为重度(70%-99%)狭窄,10.7%(n=62)为闭塞。
- 非闭塞性病变动脉中21.3%(n=123)狭窄程度进展,受影响动脉平均进展时间28.0±20.5个月。
- 467例患者中5.6%(n=26)出现症状,其中38.5%(n=10)为缺血性卒中,26.9%(n=7)为半球性短暂性脑缺血发作,11.5%(n=3)为一过性黑矇,23.1%(n=6)为其他症状。
- 577条动脉中16.6%(n=96)接受干预,其中81%(n=78)为无症状病变,19%(n=18)为有症状病变。
- 年龄较大、糖尿病和血管炎病史与狭窄进展相关,抗血小板药物使用呈减少进展趋势,头颈部肿瘤病史与症状发生正相关。
临床怎么用
- 作者认为,医生应考虑对所有颈动脉疾病患者进行长期监测,并增加对有进展危险因素患者的关注,特别是糖尿病和血管炎病史患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the natural history of internal carotid artery (ICA) stenosis progression. METHODS: This single-institution retrospective cohort study analyzed patients diagnosed with ICA stenosis of 50% or greater on duplex ultrasound from 2015 to 2022. Subjects were drawn from our institutional Intersocietal Accreditation Commission-accredited noninterventional vascular laboratory database. Primary outcomes were incidences of disease progression, and stroke or revascularization after index study. Progression was defined as an increase in stenosis classification category. Imaging, demographic, and clinical data was obtained from our institutional electronic medical record via a database mining query. Cases were analyzed at the patient and artery levels, with severity corresponding to the greatest degree of ICA stenosis on index and follow-up studies. RESULTS: Of 577 arteries in 467 patients, mean cohort age was 73.5 ± 8.9 years at the time of the index study, and 45.0% (n = 210) were female. Patients were followed with duplex ultrasound for a mean of 42.2 ± 22.7 months. Of 577 arteries, 65.5% (n = 378) at the index imaging study had moderate (50%-69%) stenosis, 23.7% (n = 137) had severe (70%-99%) stenosis, and 10.7% (n = 62) were occluded. These three groups had significant differences in age, hypertension, hyperlipidemia prevalence, and proportion on best medical therapy. Of the 467-patient cohort, 56.5% (n = 264) were on best medical therapy, defined as smoking cessation, treatment with an antiplatelet agent, statin, and antihypertensive and glycemic agents as indicated. Mean time to progression for affected arteries was 28.0 ± 20.5 months. Of those arteries with nonocclusive disease at diagnosis, 21.3% (n = 123) progressed in their level of stenosis. Older age, diabetes, and a history of vasculitis were associated with stenosis progression, whereas antiplatelet agent use trended towards decreased progression rates. Of the 467 patients, 5.6% (n = 26) developed symptoms; of those, 38.5% (n = 10) had ischemic strokes, 26.9% (n = 7) had hemispheric transient ischemic attacks, 11.5% (n = 3) had amaurosis fugax, and 23.1% (n = 6) had other symptoms. A history of head and neck cancer was positively associated with symptom development. Of 577 affected arteries, 16.6% (n = 96) underwent intervention; 81% (n = 78) of interventions were for asymptomatic disease and 19% (n = 18) were for symptomatic disease. No patient-level factors were associated with risk of intervention. CONCLUSIONS: A significant number of carotid stenosis patients experience progression of disease. Physicians should consider long-term surveillance on all patients with carotid disease, with increased attention paid to those with risk factors for progression, particularly those with diabetes and a history of vasculitis.
引用
- Harish KB, Speranza G, Rockman CB, et al. Natural history of internal carotid artery stenosis progression. J Vasc Surg. 2023. PMID: 37925038. doi:10.1016/j.jvs.2023.10.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。